financetom
Business
financetom
/
Business
/
H World Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
H World Q3 Adjusted Earnings, Revenue Rise
Nov 17, 2025 4:33 AM

07:00 AM EST, 11/17/2025 (MT Newswires) -- H World ( HTHT ) reported Q3 adjusted earnings Monday of 4.76 Chinese renminbi per ADS ($0.67), up from 4.29 renminbi a year earlier.

Two analysts surveyed by FactSet expected 4.76 renminbi.

Revenue for the quarter ended Sept. 30 was 6.96 billion renminbi, compared with 6.44 billion a year earlier.

Analysts polled by FactSet expected 6.76 billion renminbi.

Shares of the company were up 2% in recent Monday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Nov 17, 2025
02:58 PM EST, 11/17/2025 (MT Newswires) -- Jones Lang LaSalle ( JLL ) is set to benefit from improving industry tailwinds amid attractive valuation after its Q3 results, UBS Securities said in a Sunday note. The report pointed to an outlook downgrade for its Real Estate Management Services segment for the next several quarters while Q3 margin expansion disappointed, similar...
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
German Navy to purchase C$1 billion Canadian combat management system, Canada's trade minister says
German Navy to purchase C$1 billion Canadian combat management system, Canada's trade minister says
Nov 17, 2025
(Reuters) -The German Navy will purchase Lockheed Martin Canada's combat management system CMS 330 for more than C$1 billion, Canadian trade minister Maninder Sidhu announced Monday. The selection of Lockheed Martin Canada's CMS 330 by the German Navy is a testament to our world-class defence technologies and the value of government-to-government partnerships, Sidhu said in a statement. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved